Up-regulation of GnT-V may contribute to altered biological properties of lung cancer cells by increased synthesis of β1,6-GlcNAc branched N-glycans of certain target glycoproteins, resulting in inhibition of TGF-β1-induced EMT and cell motility. The gene discussed is MGAT5; the disease is lung carcinoma.